SVB Leerink Maintains Outperform on Repligen, Raises Price Target to $250

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $220 to $250.

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and raises the price target from $220 to $250.

Total
0
Shares
Related Posts